Peritoneal full-conditioning reduces postoperative adhesions and pain: a randomised controlled trial in deep endometriosis surgery
10.1186/1757-2215-6-90 · doi-reference
Progestins in the symptomatic management of endometriosis: a meta-analysis on their effectiveness and safety
10.1186/s12905-022-02122-0 · doi-reference
The 10 “cardinal sins” in the clinical diagnosis and treatment of endometriosis: a Bayesian approach
10.3390/jcm12134547 · doi-reference
Expression of transforming growth factor beta1 in nerve fibers is related to dysmenorrhea and laparoscopic appearance of endometriotic implants
10.1016/s0015-0282(03)01182-8 · doi-reference
Dysregulation of Lysyl oxidase expression in lesions and endometrium of women with endometriosis
10.1177/1933719115585144 · doi-reference
Anti-platelet therapy is efficacious in treating endometriosis induced in mouse
10.1016/j.rbmo.2016.07.007 · doi-reference
Cellular changes consistent with epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the progression of experimental endometriosis in baboons
10.1177/1933719116641763 · doi-reference
Platelets induce endothelial-mesenchymal transition and subsequent fibrogenesis in endometriosis
10.1016/j.rbmo.2020.03.020 · doi-reference
Profiling of miRNA and mRNA in eutopic and ectopic endometrial tissues in endometrioma
10.17116/repro20192502127 · doi-reference
Gene expression signature of endometrial samples from women with and without endometriosis
10.1016/j.jmig.2021.03.011 · doi-reference
Clinical significance of serum follistatin levels in the diagnosis of ovarian endometrioma and benign ovarian cysts
10.1016/j.tjog.2014.03.010 · doi-reference
MicroRNA-29b inhibits endometrial fibrosis by regulating the Sp1-TGF-β1/Smad-CTGF axis in a rat model
10.1177/1933719115602768 · doi-reference
Diagnostic value of serum activin a and follistatin levels in women with peritoneal, ovarian and deep infiltrating endometriosis
10.1093/humrep/des055 · doi-reference
PGE2 and thrombin induce myofibroblast transdifferentiation via activin a and CTGF in endometrial stromal cells
10.1210/endocr/bqab207 · doi-reference
The effect of genistein on TGF-β signal, dysregulation of apoptosis, cyclooxygenase-2 pathway, and NF-KB pathway in mice peritoneum of endometriosis model
10.1016/j.mefs.2017.05.002 · doi-reference
Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: a review
10.1002/med.21802 · doi-reference
Antifibrotic properties of epigallocatechin-3-gallate in endometriosis
10.1093/humrep/deu123 · doi-reference
Epithelial to mesenchymal transition and cell biology of molecular regulation in endometrial carcinogenesis
10.3390/jcm8040439 · doi-reference
Endometrial PTEN deficiency leads to SMAD2/3 nuclear translocation
10.3390/cancers13194990 · doi-reference
TGF-β1/Smads and miR-21 in renal fibrosis and inflammation
10.1155/2016/8319283 · doi-reference
Adenovirus-mediated P311 inhibits TGF-β1-induced epithelial-mesenchymal transition in NRK-52E cells via TGF-β1-smad-ILK pathway
10.5582/bst.2015.01129 · doi-reference
The role of TGF-beta signaling in dendritic cell tolerance
10.1007/s12026-017-8944-9 · doi-reference
Effects of pazopanib, sunitinib, and sorafenib, anti-VEGF agents, on the growth of experimental endometriosis in rats
10.1177/1933719115584448 · doi-reference
The inhibiting effect of dinitrosyl iron complexes with thiol-containing ligands on the growth of endometrioid tumours in rats with experimental endometriosis
10.1007/s12013-019-00865-6 · doi-reference
The role of TGF-β in the pathophysiology of peritoneal endometriosis
10.1093/humupd/dmx016 · doi-reference
The potential of non-invasive biomarkers for early diagnosis of asymptomatic patients with endometriosis
10.3390/jcm10132762 · doi-reference
Reconsidering evidence-based management of endometriosis
10.52054/fvvo.14.3.033 · doi-reference
Pathogenesis based diagnosis and treatment of endometriosis
10.3389/fendo.2021.745548 · doi-reference
Transforming growth factor-β1 gene polymorphisms in Korean women with endometriosis
10.1111/j.1600-0897.2011.01009.x · doi-reference
Peritoneal VEGF-A expression is regulated by TGF-β1 through an ID1 pathway in women with endometriosis
10.1038/srep16859 · doi-reference
The peritoneum is both a source and target of TGF-β in women with endometriosis
10.1371/journal.pone.0106773 · doi-reference
Elevated peritoneal soluble endoglin and GDF-15 in infertile women with severe endometriosis and pelvic adhesion
10.1016/j.jri.2021.103343 · doi-reference
Suppressive regulatory T cells and latent transforming growth factor-β-expressing macrophages are altered in the peritoneal fluid of patients with endometriosis
10.1186/s12958-018-0325-2 · doi-reference
The expression of TGF-β1, SMAD3, ILK and miRNA-21 in the ectopic and eutopic endometrium of women with endometriosis
10.3390/ijms24032453 · doi-reference
